TRUDI MARBOUGH: Open Payments
NPI 1417438748 · MONETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 29 payments from 15 companies in 2025. Trend: 2023 $64 · 2024 $381 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| PFIZER INC. | 3 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Viatris Specialty LLC | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Globus Medical, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: BREZTRI, TRINTELLIX, Ozempic, YUPELRI, Wegovy, JARDIANCE, NURTEC ODT, MOUNJARO.
Industry payments across MO — which companies pay providers there.
